Renaud Maloberti's most recent trade in ENDRA Life Sciences Inc was a trade of 186,430 Stock Options done . Disclosure was reported to the exchange on March 28, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ENDRA Life Sciences Inc | Renaud Maloberti | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 186,430 | 186,430 | - | - | Stock Options | |
| ENDRA Life Sciences Inc | Renaud Maloberti | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2021 | 25,000 | 25,000 | - | - | Stock Options | |
| ENDRA Life Sciences Inc | Renaud Maloberti | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 12 Jan 2021 | 13,696 | 1,580 | - | 1.1 | 15,066 | Common Stock |
| ENDRA Life Sciences Inc | Renaud Maloberti | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.05 per share. | 12 Jan 2021 | 6,304 | 15,276 | - | 1.0 | 6,619 | Common Stock |
| ENDRA Life Sciences Inc | Renaud Maloberti | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.94 per share. | 08 Jan 2021 | 8,731 | 21,580 | - | 0.9 | 8,207 | Common Stock |
| ENDRA Life Sciences Inc | Renaud Maloberti | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.94 per share. | 06 Jan 2021 | 11,269 | 30,311 | - | 0.9 | 10,593 | Common Stock |
| ENDRA Life Sciences Inc | Renaud Maloberti | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.73 per share. | 17 Dec 2020 | 25,000 | 41,580 | - | 0.7 | 18,250 | Common Stock |
| ENDRA Life Sciences Inc | Renaud Maloberti | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.81 per share. | 13 Nov 2020 | 10,000 | 66,580 | - | 0.8 | 8,100 | Common Stock |
| ENDRA Life Sciences Inc | Renaud Maloberti | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.72 per share. | 01 Oct 2020 | 10,000 | 76,580 | - | 0.7 | 7,200 | Common Stock |